Q1 2011

Filed May 16, 2011 · 10-Q · 46 days after period end · 0001121781-11-000144

Q1 2011 · 10-Q

Revenue

$767.00K

no prior Q1 2010 on file

Net Income

-$726.00K

no prior Q1 2010 on file

EPS Diluted

-$0.02

no prior Q1 2010 on file

Operating Income-$740,000—

Margins · derived

Same quarter

no prior Q1 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Mar 31, 2011 · filed May 16, 2011 · 46 d after period end

Guided Therapeutics Inc · CIK 924515 · Engraved from SEC EDGAR